BTIG: Buy Teva On Weakness, U.S. Lawmakers Have Little Appetite For Direct Government Negotiation Of Drug Prices
March 21, 2016 at 08:56 AM EDT
BTIG's Timothy Chiang maintained a Buy rating on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), with a $77 price ...
